Author:
Biasco Luca,Rothe Michael,Büning Hildegard,Schambach Axel
Funder
Deutsche Forschungsgemeinschaft
Bundesministerium für Bildung und Forschung
BMBF
IFB-Tx
PidNet
European Union
Gene Therapy Program of Dana-Farber/Boston Children’s Cancer and Blood Disorders Center
UCL Great Ormond Street Institute of Child Health
Subject
Genetics,Molecular Biology,Molecular Medicine
Reference45 articles.
1. Ex vivo gene transfer and correction for cell-based therapies;Naldini;Nat. Rev. Genet.,2011
2. European Medicines Agency. (2008). Guideline on the non-clinical studies required before first clinical use of gene therapy medicinal products. Committee for the medicinal products for human use (CHMP). http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003942.pdf.
3. FDA (2013). Guidance for industry: preclinical assessment of investigational cellular and gene therapy products. U.S. Department of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research. https://www.fda.gov/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/CellularandGeneTherapy/ucm376136.htm.
4. The committee for advanced therapies’ of the European Medicines Agency reflection paper on management of clinical risks deriving from insertional mutagenesis;Aiuti;Hum. Gene Ther. Clin. Dev.,2013
5. Lentiviral vector integration profiles differ in rodent postmitotic tissues;Bartholomae;Mol. Ther.,2011
Cited by
36 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献